Ticker Details
Harvard Bioscience, Inc. Harvard Bioscience Inc is a developer, manufacturer and marketer of scientific instruments, systems and lab consumables used to advance life science for basic research, drug discovery, clinical and environmental testing.
IPO Date:	April 1, 2001
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$25.94M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 2.57%
Avg Daily Range (30 D):	$0.02 | 3.81%
Avg Daily Range (90 D):	$0.03 | 4.29%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	.45M
Avg Daily Volume (90 D):	4.35M

Trade Size
Avg Trade Size (Sh.):	365
Avg Trade Size (Sh.) (30 D):	384
Avg Trade Size (Sh.) (90 D):	630

Institutional Trades
Total Institutional Trades:	159
Avg Institutional Trade:	$1.67M
Avg Institutional Trade (30 D):	$1.22M
Avg Institutional Trade (90 D):	$1.22M
Avg Institutional Trade Volume:	.43M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$5.84M
Avg Closing Trade (30 D):	$1.22M
Avg Closing Trade (90 D):	$1.22M
Avg Closing Volume:	1.52M

News

Aug 11, 2025 @ 11:12 AM Harvard Bioscience Tops Q2 Revenue Views Source: Jesterai

Jun 2, 2025 @ 8:57 PM Harvard Bioscience Appoints John Duke to Board of ... Source: N/A

May 12, 2025 @ 11:00 AM Harvard Bioscience Announces First Quarter 2025 Fi... Source: N/A

Apr 10, 2025 @ 8:45 PM Harvard Bioscience Announces CFO Transition Source: N/A

Mar 12, 2025 @ 8:00 PM Harvard Bioscience, Inc. to Participate in Two ... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.21	$-.03	$-.05
Diluted EPS	$-1.21	$-.03	$-.05
Revenue	$87.37M	$20.59M	$20.45M
Gross Profit	$49.75M	$12.02M	$11.53M
Net Income / Loss	$-53.84M	$-1.23M	$-2.28M
Operating Income / Loss	$-50.28M	$.2M	$-.82M
Cost of Revenue	$37.62M	$8.57M	$8.92M
Net Cash Flow	$1.72M	$-.54M	$1.26M
PE Ratio